Abstract A 56-year-old man with metastatic lung adenocarcinoma received combined 177 Lu-FAP-2286 radiation therapy and targeted therapy. After 1 treatment cycle, improvement of symptoms and radiological remission was observed. Moreover, the patient did not report any adverse effects.
SYLH
请叫我风吹麦浪
zho
kingwill
pcr163
Leon
yar
个性的紫菜
浦肯野
眯眯眼的衬衫
期待未来的自己
36456657
杳鸢
Hungrylunch
子车茗
天真蓝
无名老大
Loooong
简单
cc
皖公网安备34019202002308
